Lanean...
mTOR, a Potential Target to Treat Autism Spectrum Disorder
Mammalian target of rapamycin (mTOR) is a key regulator in various cellular processes, including cell growth, gene expression, and synaptic functions. Autism spectrum disorder (ASD) is frequently accompanied by monogenic disorders, such as tuberous sclerosis complex, phosphatase and tensin homolog t...
Gorde:
| Argitaratua izan da: | CNS Neurol Disord Drug Targets |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Bentham Science Publishers
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070418/ https://ncbi.nlm.nih.gov/pubmed/27071790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1871527315666160413120638 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|